CBD protected brain tissue from stroke-like damage while THC made it worse | Research

The takeaway

In rat brain slices exposed to oxygen-glucose deprivation (simulating stroke), CBD protected neurons while THC worsened damage, with opposite receptor mechanisms for each effect.

Stroke researchers, neuroscientists studying cannabinoid neuroprotection, and clinicians managing cannabis-using stroke patients.

CBD protected neurons while THC worsened ischemic brain damage

What the researchers found

CBD and the CBD-rich FM2 extract protected against ischemic brain damage in hippocampal slices. THC and the THC-rich Bedrocan extract worsened damage. THC toxicity was blocked by CB1 receptor antagonists. CBD neuroprotection was blocked by TRPV2, 5-HT1A, and PPARgamma antagonists. Confocal microscopy confirmed CBD preserved neuronal structure while THC did not.

Why it matters

Stroke is a leading cause of death and disability. Finding that CBD protects while THC harms brain tissue during ischemia has direct implications for cannabis-using stroke patients and for developing cannabinoid-based neuroprotective treatments.

The numbers in context

Bedrocan (THC-rich): worsened ischemic damage. FM2 (CBD-rich): neuroprotective. THC toxicity: blocked by CB1 antagonists. CBD protection: blocked by TRPV2, 5-HT1A, PPARgamma antagonists. CBG also tested.

How the study worked

In vitro study using rat organotypic hippocampal slices exposed to oxygen-glucose deprivation (OGD), an ischemia model. Tested cannabis extracts (Bedrocan, FM2) and individual cannabinoids (THC, CBD, CBG). Cell death measured by propidium iodide fluorescence. Receptor mechanisms explored with selective antagonists. Morphology assessed by confocal microscopy.

What this study cannot tell us

In vitro brain slice model, not in vivo stroke. Rat tissue may not directly translate to human brain. Concentrations used may not reflect real-world brain levels. Cannot account for systemic effects.

How to read the evidence

Well-controlled in vitro study with receptor mechanism identification. Preliminary for clinical translation.

When this study was published

2021 in vitro study using rat brain slices.

The bigger picture

The finding that THC/CBD ratio determines whether cannabis extracts help or harm brain tissue during ischemia suggests that not all cannabis products are equal for stroke risk. CBD-dominant products may be neuroprotective while THC-dominant products could worsen outcomes.

Questions still open

Would CBD protect human brains during stroke? Should THC-using patients be warned about increased stroke damage risk? What CBD/THC ratio optimizes neuroprotection?

Common questions

Does cannabis protect or harm the brain during stroke?

It depends on the cannabinoid. CBD protected brain tissue from stroke-like damage in this lab study, while THC worsened it. The ratio of CBD to THC in cannabis products matters.

How does CBD protect the brain?

CBD neuroprotection involved TRPV2, serotonin 5-HT1A, and PPARgamma receptors. THC damage worked through CB1 receptors. These different mechanisms mean the two cannabinoids have opposing effects on brain cells during oxygen deprivation.

Read the original research

Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids.

International journal of molecular sciences, 22(18)

View on PubMed ↗Publisher’s paper ↗

Citation

Landucci, Elisa; Mazzantini, Costanza; Lana, Daniele; Davolio, Pier Luigi; Giovannini, Maria Grazia; Pellegrini-Giampietro, Domenico E. (2021). Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids.. International journal of molecular sciences, 22(18). https://doi.org/10.3390/ijms22189773